Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 4
2004 9
2005 7
2006 7
2007 14
2008 13
2009 15
2010 34
2011 25
2012 28
2013 33
2014 48
2015 44
2016 50
2017 65
2018 72
2019 81
2020 77
2021 91
2022 92
2023 107
2024 59

Text availability

Article attribute

Article type

Publication date

Search Results

850 results

Results by year

Filters applied: . Clear all
Page 1
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects.
Fu R, Qi R, Xiong H, Lei X, Jiang Y, He J, Chen F, Zhang L, Qiu D, Chen Y, Nie M, Guo X, Zhu Y, Zhang J, Yue M, Cao J, Wang G, Que Y, Fang M, Wang Y, Chen Y, Cheng T, Ge S, Zhang J, Yuan Q, Zhang T, Xia N. Fu R, et al. Among authors: yuan q. Signal Transduct Target Ther. 2024 May 3;9(1):118. doi: 10.1038/s41392-024-01824-1. Signal Transduct Target Ther. 2024. PMID: 38702343
Glia-derived secretory fatty acid binding protein Obp44a regulates lipid storage and efflux in the developing Drosophila brain.
Yin J, Chen HL, Grigsby-Brown A, He Y, Cotten ML, Short J, Dermady A, Lei J, Gibbs M, Cheng ES, Zhang D, Long C, Xu L, Zhong T, Abzalimov R, Haider M, Sun R, He Y, Zhou Q, Tjandra N, Yuan Q. Yin J, et al. Among authors: yuan q. bioRxiv [Preprint]. 2024 Apr 11:2024.04.10.588417. doi: 10.1101/2024.04.10.588417. bioRxiv. 2024. PMID: 38645138 Free PMC article. Preprint.
Orchestrated codelivery of peptide antigen and adjuvant to antigen-presenting cells by using an engineered chimeric peptide enhances antitumor T-cell immunity.
Pan H, Yu S, Zhuang H, Yang H, Jiang J, Yang H, Ren S, Luo G, Yu X, Chen S, Lin Y, Sheng R, Zhang S, Yuan Q, Huang C, Zhang T, Li T, Ge S, Zhang J, Xia N. Pan H, et al. Among authors: yuan q. Cancer Immunol Res. 2024 Apr 17. doi: 10.1158/2326-6066.CIR-23-0926. Online ahead of print. Cancer Immunol Res. 2024. PMID: 38631019
850 results